AnalystsJohn NewmanJohn Newman's Stock Forecasts
AnalystsJohn Newman
Analyst Ranking
Bottom 20%
#3668 out of 4565 analysts
Average Return
-0.61%
Win Rate
43%18 out of 42
Risk vs Reward
Poor
Good
John Newman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +201.35% | $5.19 | $15.64 | 2022-11-15 - 2023-11-15 | Strong Buy |
Sage Therapeutics IncSAGE | +110.79% | $70.37 | $148.33 | 2017-09-12 - 2018-09-13 | Strong Buy |
Immunogen IncIMGN | +103.19% | $15.37 | $31.23 | 2023-06-04 - 2024-02-09 | Strong Buy |
Immunogen IncIMGN | +75.35% | $17.81 | $31.23 | 2023-06-11 - 2024-02-09 | Strong Buy |
Immunogen IncIMGN | +71.17% | $18.25 | $31.23 | 2023-07-31 - 2024-02-09 | Strong Buy |
John Newman Analyst Color
Get additional color on John Newman's coverage of popular stocks
John Newman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adicet Bio IncACET | 2 | Strong Buy | $19.00 | +949.72% | Reiterates | a month ago |
Arcellx IncACLX | 5 | Strong Buy | $85.00 | +65.43% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $992.00 | +11.38% | Upgrades | 8 months ago |
Immunogen IncIMGN | 5 | Strong Buy | $25.00 | -19.95% | Maintains | 9 months ago |
Oncolytics Biotech IncONCY | 2 | Strong Buy | $5.00 | +362.96% | Reiterates | 10 months ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $35.00 | +1,125.92% | Reiterates | 10 months ago |
Atara Biotherapeutics IncATRA | 1 | Strong Buy | $20.00 | +2,757.14% | Maintains | a year ago |
Seres Therapeutics IncMCRB | 3 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Global Blood Therapeutics IncGBT | 4 | Strong Buy | $72.00 | N/A | Upgrades | 2 years ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $44.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 3 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Carisma Therapeutics IncCARM | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Aileron Therapeutics IncALRN | 2 | Strong Buy | $100.00 | N/A | Maintains | 5 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $220.00 | N/A | Maintains | 6 years ago |
Aerie Pharmaceuticals IncAERI | 3 | Strong Buy | $86.00 | N/A | Maintains | 6 years ago |
Vbi Vaccines IncVBIV | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 6 years ago |
Hutchmed LtdHCM | 1 | Strong Buy | $38.00 | N/A | Maintains | 7 years ago |
Trean Insurance Group IncTIG | 2 | Strong Buy | $30.00 | N/A | Maintains | 7 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $27.00 | N/A | Maintains | 7 years ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Buy | N/A | N/A | Downgrades | 7 years ago |
Dimension Therapeutics IncDMTX | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.